{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:11:20Z","timestamp":1784311880277,"version":"3.55.0"},"reference-count":38,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,10,3]],"date-time":"2007-10-03T00:00:00Z","timestamp":1191369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Infrequently, hepatitis C (HCV) appears to be the cause of hepatic granulomas. Interferon therapy for HCV has been increasingly associated with the development of sarcoidosis.<\/jats:p><jats:p><jats:bold>Aims. <\/jats:bold> We sought to determine the incidence of hepatic granulomas in patients with recurrent HCV post liver transplantation (LT).<\/jats:p><jats:p><jats:bold>Methods. <\/jats:bold> Between 1994 and 2005, 820 patients were transplanted for HCV at our institution. The pathology database was searched for patients having recurrent HCV and granulomas. At Mount Sinai Medical Center, protocol biopsies have been performed for the last 2 years in patients receiving pegylated interferon\u2010\u03b12b and ribavirin (PEG) for recurrent HCV. Review of slides from explanted livers, pre\u2010 and post\u2010perfusion biopsies, and all allograft biopsies were evaluated. Lipogranulomas were excluded because of their frequent association with steatosis.<\/jats:p><jats:p><jats:bold>Results. <\/jats:bold> A total of 10,225 liver biopsies were performed on HCV patients, and 25 (0.24%) showed non\u2010caseating epithelioid granulomas. Hepatic granulomas were detected in 14 post\u2010LT HCV patients; 9 patients received PEG. Typically, only 1 lobular granuloma was found. None of these patients had granulomas in the native liver or in any biopsy before interferon therapy; 6\/9 patients had undetectable HCV\u2010RNA levels, and 4 had sustained viral response. No other cause for granuloma formation was identified in the 6 patients.<\/jats:p><jats:p><jats:bold>Conclusions. <\/jats:bold> Hepatic granulomas are infrequently found in HCV liver biopsies and rarely found in post\u2010LT biopsies with recurrent HCV. When present, they occur more commonly in patients receiving and virologically responding to PEG therapy. The presence of granulomas in patients with HCV being treated with PEG may not warrant an extensive etiologic work\u2010up for granulomatous hepatitis unless otherwise clinically indicated.<\/jats:p>","DOI":"10.1111\/j.1399-3062.2007.00258.x","type":"journal-article","created":{"date-parts":[[2007,10,3]],"date-time":"2007-10-03T08:56:33Z","timestamp":1191401793000},"page":"184-189","source":"Crossref","is-referenced-by-count":22,"title":["Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation"],"prefix":"10.1111","volume":"10","author":[{"given":"M.I.","family":"Fiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.D.","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,10,3]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-47527-8_17"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80244-2"},{"key":"e_1_2_5_4_2","first-page":"596","article-title":"Disease recurrence after living liver transplantation for primary biliary cirrhosis","volume":"7","author":"Hashimoto E","year":"2001","journal-title":"a clinical and histological follow-up study"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2005.00372.x"},{"key":"e_1_2_5_6_2","first-page":"1611","article-title":"Recurrent hepatic sarcoidosis post\u2010liver transplantation manifesting with severe hypercalcemia","volume":"11","author":"Cengiz C","year":"2005","journal-title":"a case report and review of the literature"},{"key":"e_1_2_5_7_2","first-page":"850","article-title":"Hepatic granulomas","volume":"56","author":"Gaya DR","year":"2003","journal-title":"a 10 year single center experience"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1996.d01-418.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(93)90189-N"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200405000-00011"},{"key":"e_1_2_5_11_2","first-page":"216","article-title":"Epithelioid cell granulomas in chronic hepatitis C","volume":"33","author":"Harada K","year":"1998","journal-title":"immunohistochemical character and histological marker of favourable response to interferon-\u03b1 therapy"},{"key":"e_1_2_5_12_2","first-page":"291","article-title":"Epitheloid granuloma formation in type C chronic hepatitis","volume":"42","author":"Yamamoto S","year":"1995","journal-title":"report of two cases"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)32182-9"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200110000-00020"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcp.0000134400.88832.9c"},{"key":"e_1_2_5_16_2","first-page":"432","article-title":"Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C \u2013 a case report and review of the literature","volume":"68","author":"Bolukbas C","year":"2005","journal-title":"Acta Gastroenterol Belg"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000160442.23523.0a"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.7.865"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2005.00651.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018806508474"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02208993"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199804000-00013"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2005.00746.x"},{"issue":"1","key":"e_1_2_5_24_2","first-page":"40","article-title":"Hepatic granulomas","volume":"30","author":"Lefkowitch JH.","year":"1999","journal-title":"J Hepatol"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1994.tb01320.x"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2003.11.023"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00795-005-0289-0"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150402"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(05)70016-7"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2005.05.004"},{"key":"e_1_2_5_31_2","first-page":"1724","article-title":"Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C","volume":"39","author":"Midturi J","year":"2004","journal-title":"case report and review of the literature"},{"key":"e_1_2_5_32_2","first-page":"237","article-title":"Sarcoidosis and interferon therapy","volume":"14","author":"Leclerc S","year":"2003","journal-title":"report of five cases and review of the literature"},{"key":"e_1_2_5_33_2","first-page":"529","article-title":"Sarcoidosis occurring after interferon\u2010\u03b1 therapy for chronic hepatitis C","volume":"10","author":"Hirano A","year":"2005","journal-title":"report of two cases"},{"key":"e_1_2_5_34_2","first-page":"883","article-title":"Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C","volume":"14","author":"Gitlin N.","year":"2002","journal-title":"a report of two cases"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199806150-00015"},{"key":"e_1_2_5_36_2","first-page":"1765","article-title":"Granulomatous destruction of bile ducts after liver transplantation","volume":"21","author":"Farges O","year":"1995","journal-title":"primary biliary cirrhosis recurrence or hepatitis C virus infection?"},{"key":"e_1_2_5_37_2","first-page":"325","article-title":"Sarcoidosis with selective involvement of a second liver allograft","volume":"12","author":"Hunt J","year":"1999","journal-title":"report of a case and review of the literature"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20706"},{"key":"e_1_2_5_39_2","first-page":"483A","article-title":"\u201cDe novo\u201d autoimmune disorders in liver transplanted patients treated with pegylated interferon\u2010alfa\u20102b and ribavirin for hepatitis C recurrence","volume":"42","author":"Gerardi S","year":"2005","journal-title":"Hepatology"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2007.00258.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2007.00258.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T15:20:38Z","timestamp":1697296838000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2007.00258.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1111\/j.1399-3062.2007.00258.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2007.00258.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,3]]}}}